Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta12,14-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway

Life Sciences

Volumn 112, Issue 1-2, 2014, Pages 82-89

  Seo, Su Kil ^a   Seo, Dae Il ^b   Park, Won Sun ^c   Jung, Won Kyo ^d   Lee, Dae Sung ^e   Park, Sae Gwang ^a   Choi, Jung Sik ^f   Kang, Mi Seon ^a   Choi, Young Hyun ^g   Choi, Inhak ^a   Yu, Byeng Chul ^b   Choi, Il Whan ^a  

^a Inje University   (South Korea)

^b Kosin University   (South Korea)

^c Kangwon National University   (South Korea)

^d Pukyong National University   (South Korea)

^e Marine Biodiversity Institute of Korea   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Dong Eui University   (South Korea)

Author keywords

15 Deoxy delta12,14 prostaglandin J2 inhibits; B7 H1 expression; B7 H1, 15 deoxy 12,14 prostaglandin J2; Costimulatory molecules; Interferon regulatory factor 1; Peroxisome proliferator activated receptor gamma; Signal transducer(s) and activator(s) of transcription

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; JANUS KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGRAMMED DEATH 1 LIGAND 1; STAT PROTEIN; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; CD274 PROTEIN, MOUSE; PROSTAGLANDIN D2;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; MELANOMA CELL LINE; MOLECULE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; EXPERIMENTAL MELANOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANILIDES; ANIMALS; ANTIGENS, CD274; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; JANUS KINASES; MELANOMA, EXPERIMENTAL; MICE; PPAR GAMMA; PROSTAGLANDIN D2; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84908647853     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.07.021     Document Type: Article

References (42)

1. Aiba S, Manome H, Yoshino Y, Tagami H. Alteration in the production of IL-10 and IL-12 and aberrant expression of CD23, CD83 and CD86 by monocytes or monocyte-derived dendritic cells from atopic dermatitis patients. Exp Dermatol 2003;12:86-95.
2. Andrianifahanana M, Singh AP, Nemos C, Ponnusamy MP, Moniaux N, Mehta PP, et al. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response. Oncogene 2007;26:7251-61.
3. 2 in the regulation of microglial functions. Eur J Neurosci 2000;12:2215-23.
4. Blank C, Kuball J, Voelkl S, Wiendl H, Becker B, Walter B, et al. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer 2006;119:317-27.
5. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to IFN-gamma. Annu Rev Immunol 1997;15:749-95.
6. 2. Cell Growth Differ 2000;11:49-61.
7. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336-47.
8. 2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J Immunol 2003;171:979-88.
9. Clay CE, Namen AM, Atsumi G, Willingham MC, High KP, Kute TE, et al. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis 1999;20:1905-11.
10. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA. Inhibition of inducible nitric oxide synthase by PPAR agonists: correlation with induction of heme oxygenase 1. J Immunol 1998;161:978-84.
11. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-21.
12. Dong H, Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J Mol Med 2003;81:281-7.
13. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999;5:1365-9.
14. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002;8:793-800.
15. 2 represses nitric oxide, TNF-α, and IL-12 production bymicroglial cells. J Neuroimmunol 2001;115:28-35.
16. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000;192:1027-34.
17. 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of PPAR-gamma. J Immunol 2004;173:5196-208.
18. Gruschwitz MS, Vieth G. Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by IFN-gamma and tumor necrosis factor alpha in the early disease stage. Arthritis Rheum 1997;40:540-50.
19. 2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Biochem Biophys Res Commun 2003;302:415-20.
20. Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune\ system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A 2002;99:12293-7.
21. Kalvakolanu DV, Borden EC. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest 1996;14:25-53.
22. Kim J, Myers AC, Chen L, Pardoll DM, Truong-Tran QA, Lane AP, et al. Constitutive and inducible expression of B7 family of ligands by human airway epithelial cells. Am J Respir Cell Mol Biol 2005;33:280-9.
23. Lee SJ, Jang BC, Lee SW, Yang YI, Suh SI, Park YM, et al. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett 2006;580:755-62.
24. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, et al. Terminal differentiation of human breast cancer through PPAR-gamma. Mol Cell 1998;1:465-70.
25. 2, reduces neutrophil migration via a nitric oxide pathway. J Immunol 2008;180:609-17.
26. 2 induce apoptosis in normal andmalignant B-lineage cells. J Immunol 2000;165:6941-8.
27. 2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J Biol Chem 2003;278:14747-52.
28. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by PPAR-gamma activators. Circulation 2000;101:235-8.
29. 2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPAR gamma-independent mechanisms. J Immunol 2006;177:5068-76.
30. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The PPAR-gamma is a negative regulator of macrophage activation. Nature (London) 1998;391:79-82.
31. Ricote M, Huang JT, Welch JS, Glass CK. The PPAR-gamma as a regulator of monocyte/macrophage function. J Leukoc Biol 1999;66:733-9.
32. Rosen ED, Spiegelman BM. PPAR-gamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276:37731-4.
33. Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, et al. Differentiation and reversal of malignant changes in colon cancer through PPAR-gamma. Nat Med 1998;4:1046-52.
34. Schindler C, Darnell Jr JE. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995;64:621-51.
35. Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 2004;34:201-8.
36. 2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. Biochem Pharmacol 2011;82:1335-51.
37. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al. Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A 2004;101:17174-9.
38. Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, et al. Terminal differentiation of human liposarcoma cells induced by ligands for PPAR-gamma and the retinoid X receptor. Proc Natl Acad Sci U S A 1991;94:237-41.
39. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPAR-gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998;93:241-52.
40. 2. Biochem Biophys Res Commun 2001;283:750-5.
41. Vamecq J, Latruffe N. Medical significance of PPAR. Lancet 1999;354:141-8.
42. Xu Y, Iyengar S, Roberts RL, Shappell SB, Peehl DM. Primary culture model of PPAR gamma activity in prostate cancer cells. J Cell Physiol 2003;196:131-43.